4/A//SEC Filing
Salkind Gene 4/A
Accession 0001683168-24-005963
CIK 0001084267other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:00 PM ET
Size
7.5 KB
Accession
0001683168-24-005963
Insider Transaction Report
Form 4/AAmended
Salkind Gene
Director10% Owner
Transactions
- Conversion
Common Stock
2024-08-06$0.20/sh+7,675,160$1,535,032→ 8,223,695 total - Conversion
Series H Preferred Stock
2024-08-06−751,973→ 581,544 totalExercise: $0.20From: 2023-12-15→ Common Stock (7,519,730 underlying)
Footnotes (4)
- [F1]Not applicable.
- [F2]The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust.
- [F3]Includes dividend shares issued upon conversion.
- [F4]Includes (i) 420,000 common shares underlying convertible notes, (ii) 59,211 shares underlying warrants exercisable at $60 per share, (iii) 2,333 shares underlying options exercisable at $68.48 per share and (iv) 100,000 shares underlying options exercisable at $.20 per share.
Documents
Issuer
Mobiquity Technologies, Inc.
CIK 0001084267
Entity typeother
Related Parties
1- filerCIK 0001592481
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:00 PM ET
- Size
- 7.5 KB